Why the study?
Does serum NT-proBNP level correlate with echocardiographic evidence of left ventricular hypertrophy and systolic dysfunction in hypertensive patients?
Cross-Sectional (n=31)
No
Does serum NT-proBNP level correlate with echocardiographic evidence of left ventricular hypertrophy and systolic dysfunction in hypertensive patients?
Mean Difference: 795.6
Absolute Event Rate: 852% vs 56.4%
p-value: p=0.021
NT-proBNP serum levels significantly rise when left ventricular systolic dysfunction develops in patients with hypertension, correlating with echocardiographic structural and functional deterioration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Asterina et al. (2018) conducted a cross-sectional in Hypertension and Hypertensive Heart Disease (n=31). Hypertensive heart disease with left ventricular systolic dysfunction vs. Hypertension with normal echocardiography was evaluated on NT-proBNP serum level (pg/mL) (MD 795.6, p=0.021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: